Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study.
about
Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@ast
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@en
type
label
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@ast
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@en
prefLabel
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@ast
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@en
P2093
P2860
P1476
Pharmacokinetics and safety of ...... el, single-arm, phase I study.
@en
P2093
Andrew Spencer
Chris Morris
Darrell White
Divaya Bhutani
Hang Quach
Martin Gyger
Mike White
Sandeep Inamdar
P2860
P2888
P304
P356
10.1007/S00280-017-3287-8
P577
2017-04-19T00:00:00Z
P6179
1084932028